Curcumin Derivative MTH-3 Regulates Palmitate-induced Insulin Resistance in Mouse Myoblast C2C12 Cells

In Vivo. 2021 Nov-Dec;35(6):3181-3191. doi: 10.21873/invivo.12613.

Abstract

Background/aim: At present, there are no effective drugs for the treatment of insulin resistance. MTH-3, a curcumin derivative, exerts potent anti-cancer effects. The aim of the present study was to explore whether MTH-3 is capable of regulating palmitic acid (PA)-induced insulin resistance in C2C12 cells.

Materials and methods: Cell viability was examined using the MTT assay. C2C12 cells were treated with PA and evaluated for the production of oil droplets using an Oil Red O assay. Glucose uptake was analysed by the 2-NBDG assay.

Results: Treatment of cells with up to 500 μM PA for 24 h or with 5 or 10 μM MTH-3 had no effect on cell viability. PA induced production of oil droplets in C2C12 cells. After adding MTH-3, the quantity of oil droplets decreased significantly and glucose uptake recovered.

Conclusion: MTH-3 may become an efficient drug for the treatment of insulin resistance and associated diseases.

Keywords: Curcumin derivative; MTH-3; insulin resistance; mouse myoblast cells; palmitic acid.

MeSH terms

  • Animals
  • Cell Line
  • Curcumin* / pharmacology
  • Insulin
  • Insulin Resistance*
  • Mice
  • Myoblasts
  • Palmitates

Substances

  • Insulin
  • Palmitates
  • Curcumin